Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkami Technology (ALKT) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Alkami Technology (ALKT) over the last 6 years, with Q3 2025 value amounting to $77.0 million.

  • Alkami Technology's Operating Expenses rose 2617.41% to $77.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.5 million, marking a year-over-year increase of 2625.22%. This contributed to the annual value of $241.3 million for FY2024, which is 1609.12% up from last year.
  • As of Q3 2025, Alkami Technology's Operating Expenses stood at $77.0 million, which was up 2617.41% from $81.5 million recorded in Q2 2025.
  • Over the past 5 years, Alkami Technology's Operating Expenses peaked at $81.5 million during Q2 2025, and registered a low of $26.7 million during Q1 2021.
  • Its 5-year average for Operating Expenses is $51.2 million, with a median of $52.3 million in 2023.
  • In the last 5 years, Alkami Technology's Operating Expenses tumbled by 557.38% in 2022 and then surged by 5532.46% in 2023.
  • Alkami Technology's Operating Expenses (Quarter) stood at $36.2 million in 2021, then fell by 5.57% to $34.2 million in 2022, then soared by 55.32% to $53.0 million in 2023, then increased by 16.57% to $61.8 million in 2024, then increased by 24.56% to $77.0 million in 2025.
  • Its Operating Expenses stands at $77.0 million for Q3 2025, versus $81.5 million for Q2 2025 and $73.2 million for Q1 2025.